Novel mass spectrometric immunoassays for the rapid structural characterization of plasma apolipoproteins

Journal of Lipid Research

Volumn 44, Issue 3, 2003, Pages 630-639

  Niederkofler, Eric E ^a   Tubbs, Kemmons A ^a   Kiernan, Urban A ^a   Nedelkov, Dobrin ^a   Nelson, Randall W ^a  

^a Intrinsic Bioprobes Incorporated   (United States)

Author keywords

Affinity capture; apoA II; apoE; MALDI TOF MS; Phenotype; Point mutations; Posttranslational modifications

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN C1; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; APOLIPOPROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ANALYTIC METHOD; ARTICLE; CASE REPORT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; IMMUNOASSAY; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN STRUCTURE; SENSITIVITY AND SPECIFICITY; TRANSLATION REGULATION; BLOOD; CHEMISTRY; METHODOLOGY;

ADULT; AGED; APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; APOLIPOPROTEINS; APOLIPOPROTEINS E; HUMANS; IMMUNOASSAY; MALE; MASS SPECTROMETRY;

EID: 0038281517     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.D200034-JLR200     Document Type: Article

References (27)

1. Emi, M., L. L. Wu, M. A. Robertson, R. L. Myers, R. A. Hegele, R. R. Williams, R. White, and J. M. Lalouel. 1988. Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics. 3: 373-379.
2. Baron, H., S. Fung, A. Aydin, S. Bahring, E.Jeschke, F. C. Luft, and H. Schuster. 1997. Oligonucleotide ligation assay for detection of apolipoprotein E polymorphisms. Clin. Chem. 43: 1984-1986.
3. Tsai, M. Y., P. Suess, K. Schwichtenberg, J. H. Eckfeldt, J. Yuan, M. Tuchman, and D. Hunninghake. 1993. Determination of apolipoprotein E genotypes by single-strand conformational polymorphism. Clin. Chem. 39: 2121-2124.
4. Hixson, J. E., and D. T. Vernier. 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31: 545-548.
5. Kohler, T., A-K. Rost, K. Purschwitz, S. Vondran, H. Remke, O. Wagner, and V. Richter. 2000. Genotyping of human apolipoprotein E alleles by the new qualitative, microplate-based CASSI-detection assay. In Polymorphism detection and analysis. J. Burczak, E. Mardis, editors. Eaton Publishing. Natick, MA. 397-405.
6. Little, D. P., A. Braun, B. Darnhofer-Demar, and H. Koster. 1997. Identification of apolipoprotein E polymorphisms using temperature cycled primer oligo base extension and mass spectrometry. Eur. J. Clin. Chem. Clin. Biochem. 35: 545-548.
7. Watkins, L. K., P. V. Bondarenko, D. C. Barbacci, S. Q. Song, S. L. Cockrill, D. H. Russell, and R. D. Macfarlane. 1999. Fast C-18 solid-phase desalting/delipidation of the human serum apolipoproteins for matrix-assisted laser desorption ionization and electrospray ionization mass spectrometric analysis. J. Chromatogr. A. 840: 183-193.
8. Bondarenko, P. V., S. L. Cockrill, L. K. Watkins, I. D. Cruzado, and R. D. Macfarlane. 1999. Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein. J. Lipid Res. 40: 543-555.
9. Dayal, B., and N. H. Ertel. 2002. Proteinchip technology: a new and facile method for the identification and measurement of high-density lipoproteins apoA-I and apoA-II and their glycosylated products in patients with diabetes and cardiovascular disease. J. Proteome. Res. 1: 375-380.
10. Niederkofler, E. E., K. A. Tubbs, K. Gruber, D. Nedelkov, U. A. Kiernan, P. Williams, and R. W. Nelson. 2001. Determination of beta-2 microglobulin levels in plasma using a high-throughput mass spectrometric immunoassay system. Anal. Chem. 73: 3294-3299.
11. Nelson, R. W., J. R. Krone, A. L. Bieber, and P. Williams. 1995. Mass-Spectrometric Immunoassay. Anal. Chem. 67: 1153-1158.
12. Tubbs, K. A., D. Nedelkov, and R. W. Nelson. 2001. Detection and quantification of beta-2-microglobulin using mass spectrometric immunoassay. Anal. Biochem. 289: 26-35.
13. Kiernan, U. A., K. A. Tubbs, K. Gruber, D. Nedelkov, E. E. Niederkofler, P. Williams, and R. W. Nelson. 2002. High-through-put protein characterization using mass spectrometric immunoassay. Anal. Biochem. 301: 49-56.
14. Frank, P. G., and Y. L. Marcel. 2000. Apolipoprotein A-I: structure-function relationships. J. Lipid Res. 41: 853-872.
15. Deterding, L. J., J. M. Cutalo, M. Khaledi, and K. B. Tomer. 2002. Separation and characterization of human high-density apolipoproteins using a nonaqueous modifier in capillary electrophoresis-mass spectrometry. Electrophoresis. 23: 2296-2305.
16. Bondarenko, P. V., Z. N. Farwig, C. J. McNeal, and R. D. Macfarlane. 2002. MALDI- and ESI-MS of the HDL apolipoproteins; new isoforms of apoA-I, II. Int. J. Mass. Spectrom. 219: 671-680.
17. Jordan, J., M. F. Galindo, R. J. Miller, C. A. Reardon, G. S. Getz, and M. J. LaDu. 1998. Isoform-specific effect of apolipoprotein E on cell survival and beta- amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures. J. Neurosci. 18: 195-204.
18. Yamauchi, K., M. Tozuka, T. Nakabayashi, M. Sugano, H. Hidaka, Y. Kondo, and T. Katsuyama. 1999. Higher avidity binding of apolipoprotein (E-AII) complex than of apolipoprotein E monomer to beta-amyloid. J. Neurosci. Res. 58: 301-307.
19. Yamauchi, K., M. Tozuka, H. Hidaka, T. Nakabayashi, M. Sugano, Y. Kondo, A. Nakagawara, and T. Katsuyama. 2000. Effect of apolipoprotein AII on the interaction of apolipoprotein E with beta-amyloid: some apo(E-AII) complexes inhibit the internalization of beta-amyloid in cultures of neuroblastoma cells. J. Neurosci. Res. 62: 608-614.
20. Mahley, R. W., and Y. Huang. 1999. Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond. Curr. Opin. Lipidol. 10: 207-217.
21. Menzel, H. J., R. G. Kladetzky, and G. Assmann. 1983. Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis. 3: 310-315.
22. Davignon, J., R. E. Gregg, and C. F. Sing. 1988. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8: 1-21.
23. Booth, D. R., S. Y. Tan, S. E. Booth, J. J. Hsuan, N. F. Totty, O. Nguyen, T. Hutton, D. M. Vigushin, G. A. Tennent, W. L. Hutchinson, N. Thomson, A. K. Soutar, P. N. Hawkins, and M. B. Pepys. 1995. A new apolipoprotein AI variant, Trp50Arg, causes hereditary amyloidosis. Q. J. Med. 88: 695-702.
24. Booth, D. R., S. Y. Tan, S. E. Booth, G. A. Tennent, W. L. Hutchinson, J. J. Hsuan, N. F. Totty, O. Truong, A. K. Soutar, P. N. Hawkins, M. Bruguera, J. Caballeria, M. Sole, J. M. Campistol, and M. B. Pepys. 1996. Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene. J. Clin. Invest. 97: 2714-2721.
25. Persey, M. R., D. R. Booth, S. E. Booth, R. van Zyl-Smit, B. K. Adams, A. B. Fattaar, G. A. Tennent, P. N. Hawkins, and M. B. Pepys. 1998. Hereditary nephropathic systemic amyloidosis caused by a novel variant apolipoprotein A-I. Kidney Int. 53: 276-281.
26. Soutar, A. K., P. N. Hawkins, D. M. Vigushin, G. A. Tennent, S. E. Booth, T. Hutton, O. Nguyen, N. F. Totty, T. G. Feest, J. J. Hsuan, and M. B. Pepys. 1992. Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis. Proc. Natl. Acad. Sci. USA. 89: 7389-7393.
27. Ridley, M. 1999. Genome. Harper Collins Publishing, New York.